MedTech News
.................... by Andrew Celentano
Microneedles may help light reach hard-to-treat skin cancers
Photodynamic therapy (PDT) uses a light-sensitive drug and a specific wavelength of light to destroy cancer cells. The treatment has become an important option for certain skin cancers because it can target diseased tissue while limiting damage to surrounding skin. But PDT has a fundamental challenge: both the drug and the light must reach the same area of tissue.
What to know about the record-setting Cyclospora outbreak
Two Northwestern experts explain how to reduce risk without sacrificing a healthy diet
Philips gets FDA nod for next-gen reusable pulse oximetry clip sensor
Philips (NYSE:PHG) today announced that it received FDA 510(k) clearance for its next-generation reusable SpO₂ clip sensor.
Casana introduces smart toilet seat that measures blood pressure, heart rate
Casana announced today that it launched the Smart Seat, a smart toilet seat capable of measuring a range of metrics.
Tumor organoid tech advances precision medicine cancer treatments
Significant advances have been made in the development of patient-derived tumor “organoids” for preclinical research in two new studies led by Weill Cornell Medicine investigators. Organoids are three-dimensional clumps of cells that mimic structural and functional features of an organ, tumor or other tissue. The advances represent progress in precision medicine and point to the more routine use of tumor organoids as models for evaluating and optimizing cancer treatments.
Consano Bio Receives FDA Investigational New Drug Clearance to Expand the C-1101 Chronic Sciatica Clinical Development Program into the United States
BURLINGTON, Mass., July 20, 2026 /PRNewswire/ — Consano Bio, Inc., a clinical-stage biotechnology company advancing novel therapeutics designed to address serious, painful orthopedic conditions, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application for C-1101, its lead investigational therapy for chronic painful lumbosacral radiculopathy (LSR), commonly known as chronic sciatica.
Seegene USA Receives FDA Emergency Use Authorization for Multiplex PCR Assay, Advancing Differential Diagnosis of HSV-1&2, VZV, and Monkeypox Virus for Ulcerative Skin Lesions
SEOUL, South Korea, July 21, 2026 /PRNewswire/ — Seegene, Inc. (“Seegene”), a global leader in molecular diagnostics, announced today that its U.S. subsidiary, Seegene USA, Inc. (“Seegene USA”), has received an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the Allplex™ HSV-1&2/VZV/MPXV Assay, a multiplex real-time PCR assay designed to simultaneously detect multiple viral pathogens associated with clinically overlapping lesion presentations.
Medtrum to bring 300U tubeless insulin patch pump to Germany
Medtrum announced today that it made further progress toward bringing its 300-unit tubeless insulin patch pump to the German market.